Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 110 results for "Chronic Lymphocytic Leukemia (CLL)".

Thumbnail for Temporal Trends and Demographic Disparities in Non-ALL Lymphoid Leukemia Mortality in the United States, 1999-2025: A CDC WONDER Analysis

CLL - 1241

Temporal Trends and Demographic Disparities in Non-ALL Lymphoid Leukemia Mortality in the United States, 1999-2025: A CDC WONDER Analysis

Pari Kotak

Poster Presenter: Pari Kotak

Thumbnail for Evolution of Infection-Associated Mortality Among Decedents With Chronic Lymphocytic Leukemia: A 22-Year National Multiple-Cause-of-Death Analysis, 2003-2024

CLL - 1256

Evolution of Infection-Associated Mortality Among Decedents With Chronic Lymphocytic Leukemia: A 22-Year National Multiple-Cause-of-Death Analysis, 2003-2024

Kristina Agustino

Poster Presenter: Kristina Agustino

Previous 1 2 3 4 5 6...13 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Pirtobrutinib, Venetoclax, and Obinutuzumab Treatment in First-Line CLL (PIVOT-CLL)

CLL - 1265

Pirtobrutinib, Venetoclax, and Obinutuzumab Treatment in First-Line CLL (PIVOT-CLL)

Nitin Jain

Poster Presenter: Nitin Jain

Thumbnail for Hematologic Toxicity and Treatment Discontinuation With Venetoclax-Based Regimens in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

CLL - 1272

Hematologic Toxicity and Treatment Discontinuation With Venetoclax-Based Regimens in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

Rishi Nanda

Poster Presenter: Rishi Nanda

Thumbnail for Prognostic Impact of TP53 Disruption in Richter Transformation: A Systematic Review and Hazard Ratio Meta-Analysis of Survival Outcomes

CLL - 1278

Prognostic Impact of TP53 Disruption in Richter Transformation: A Systematic Review and Hazard Ratio Meta-Analysis of Survival Outcomes

Aima Azhar

Poster Presenter: Aima Azhar

Thumbnail for Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

CLL - 1282

Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

Rishi Nanda

Poster Presenter: Rishi Nanda

Thumbnail for Trends and Disparities in Inpatient Systemic Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the United States, 2016-2022

CLL - 1285

Trends and Disparities in Inpatient Systemic Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the United States, 2016-2022

Xiaoyi Zhang

Poster Presenter: Xiaoyi Zhang

Thumbnail for Comparative Safety of Ibrutinib vs. Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity-Score-Matched Analysis of Real-World Outcomes

CLL - 1304

Comparative Safety of Ibrutinib vs. Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity-Score-Matched Analysis of Real-World Outcomes

Muhammad Usman Haider

Poster Presenter: Muhammad Usman Haider

Thumbnail for Anticoagulation Safety and Thromboembolic Outcomes in Patients With Chronic Lymphocytic Leukemia and Atrial Fibrillation Receiving BTK Inhibitors: A Propensity-Matched TriNetX Analysis

CLL - 1309

Anticoagulation Safety and Thromboembolic Outcomes in Patients With Chronic Lymphocytic Leukemia and Atrial Fibrillation Receiving BTK Inhibitors: A Propensity-Matched TriNetX Analysis

Jude Ossai

Poster Presenter: Jude Ossai

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors